International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 4 , Pages 1029-1034 , 15 November 2009

Benefit of Radiation Boost After Whole-Breast Radiotherapy

  • Lorenzo Livi, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
    • Corresponding Author InformationReprint requests to: Lorenzo Livi, M.D., Radiotherapy Unit, University of Florence, Viale Morgagni no. 85, 50134 Florence, Italy. Tel: +39 055 7947719; Fax: +39 055 437930
  • ,
  • Simona Borghesi, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Calogero Saieva, M.D.

      Affiliations

    • Molecular and Nutritional Epidemiology Unit, ISPO, Cancer Prevention and Research Institute, Florence, Italy
  • ,
  • Massimiliano Fambrini, M.D.

      Affiliations

    • Department of Gynaecology, Perinatology and Human Reproduction, University of Florence, Florence, Italy
  • ,
  • Alberto Iannalfi, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Daniela Greto, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Fabiola Paiar, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Silvia Scoccianti, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Gabriele Simontacchi, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Simonetta Bianchi, M.D.

      Affiliations

    • Department of Pathology, University of Florence, Florence, Italy
  • ,
  • Luigi Cataliotti, M.D.

      Affiliations

    • Department of Surgery, University of Florence, Florence, Italy
  • ,
  • Giampaolo Biti, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy

Received 19 September 2008 ,Revised 3 December 2008 ,Accepted 8 December 2008.

References 

  1. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–1232
  2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241
  3. Livi L, Paiar F, Saieva C, et al. Survival and breast relapse in 3834 patients with T1–T2 breast cancer after conserving surgery and adjuvant treatment. Radiother Oncol. 2007;82:287–293
  4. Early Breast Cancer Trialists Collaborative Group (EBCTCG). Effects of radiotherapy and differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trial. Lancet. 2004;366:2087–2106
  5. Poortmans PM, Collette L, Bartelink H, et al. on behalf of the EORTC Radiation Oncology and Breast Cancer Groups The addition of a boost dose on the primary tumor bed after lumpectomy in breast conserving treatment for breast cancer. A summol/lary of the results of EORTC 22881–10882 “boost versus no boost” trial. Cancer Radiother. 2008;12:565–570
  6. Poortmans PM, Collette L, Horiot JC, et al. on behalf of the EORTC Radiation Oncology and Breast Cancer Groups. Impact of the boost dose of 10Gy versus 26Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-Year results of the randomised EORTC boost trial. Radiother Oncol. 2009;90:80–85
  7. Clark RM, McCulloch PB, Levine MN, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992;84:683–689
  8. Uppsala-Oreboro Breast Cancer Study Group. Sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Natl Cancer Inst. 1990;82:277–282
  9. Romestaing P, Lehinge Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J Clin Oncol. 1997;15:963–968
  10. Polgar C, Fodor J, Orosz Z, et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I–II breast cancer: First results of the randomized Budapest boost trial. Strahlenther Onkol. 2002;178:615–623
  11. Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345:1378–1387
  12. International Commol/lission of Radiation Units and Measurements: Dose specification for reporting external beam therapy with photons and electrons. Report 50. Bethesda, MD: ICU; 1992;
  13. Liliegren G, Holmberg L, Bergh J, et al. Ten-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol. 1999;17:2326–2333
  14. Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-Year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet. 1996;348:708–713
  15. Pötter R, Gnant M, Kwasny W, et al. Austrian Breast and Colorectal Cancer Study Group. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys. 2007;68:334–340
  16. Arthur DW, Cuttino LW, Neuschatz AC, et al. Tumor bed boost omission after negative re-excision in breast-conservation treatment. Ann Surg Oncol. 2006;13:794–801
  17. Graham P, Fourquet A. Placing the boost in breast-conservation radiotherapy: A review of the role, indications and techniques for breast-boost radiotherapy. Clin Oncol. 2006;18:210–219
  18. Notani M, Uchida N, Kitagaki H. Role of 10-Gy boost radiation after breast-conserving surgery for stage I–II breast cancer with a 5-mm negative margin. Int J Clin Oncol. 2007;12:261–267
  19. Pritchard KI. Adjuvant therapy of the very young woman. Breast. 2007;16(Suppl 2):S136–S146
  20. Maingon P, Chapet O, Barillot I, et al. To boost the tumor bed: The age of reason. Cancer Radiother. 2004;8:33–38
  21. Vrieling C, Collette L, Fourquet A, et al. EORTC Radiotherapy, Breast Cancer Groups. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?. Eur J Cancer. 2003;39:932–944
  22. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of higher radiation dose on local control and survival in breast conserving therapy of early breast cancer: 10-Year results of the randomized boost versus no boost EORTC 22881-10883 trial. J Clin Oncol. 2007;25:3259–3265
  23. Antonini N, Jones H, Horiot JC, et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol. 2007;82:265–271
  24. Algara López M, Sanz Latiesas X, Foro Arnalot P, et al. Risk factors of local relapse in breast cancer: The importance of age. Clin Transl Oncol. 2007;9:110–116
  25. Sautter-Bihl ML, Budach W, Dunst J, et al. DEGRO practical guidelines for radiotherapy of breast cancer I: Breast-conserving therapy. Strahlenther Onkol. 2007;183:661–666
  26. Carlson RW, Allred DC, Anderson BO, et al. NCCN Practice Guidelines in Oncology—v.1 2009 Breast Cancer. Available at: www.nccn.org.
  27. Neuschatz AC, DiPetrillo T, Safaii H, et al. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer. 2003;97:30–39
  28. Vordermark D, Lackenbauer A, Wulf J, et al. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy. Oncol Rep. 2007;18:1335–1339

 Conflict of interest: none.

PII: S0360-3016(09)00025-X

doi: 10.1016/j.ijrobp.2008.12.038

International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 4 , Pages 1029-1034 , 15 November 2009